New studies are revealing how medications that act on the glucagon-like peptide-1 (GLP-1) system influence brain networks tied to nausea, thirst, and reward-driven behaviors. GLP-1 drugs include commonly used treatments such as semaglutide…
Continue Reading
News Source: www.sciencedaily.com

Leave a Reply